Please ensure Javascript is enabled for purposes of website accessibility
Home > Products > Recombinant Proteins > Immune Checkpoint Proteins

Human CD27 Ligand/TNFSF7/CD70 Recombinant Protein (C-Fc) (HB796011)

Human CD27 Ligand/TNFSF7/CD70 Recombinant Protein (C-Fc)
Human CD27 Ligand/TNFSF7/CD70 Recombinant Protein (C-Fc)
Human CD27 Ligand/TNFSF7/CD70 Recombinant Protein (C-Fc)
Human CD27 Ligand/TNFSF7/CD70 Recombinant Protein (C-Fc)
Human CD27 Ligand/TNFSF7/CD70 Recombinant Protein (C-Fc)
Human CD27 Ligand/TNFSF7/CD70 Recombinant Protein (C-Fc)
Human CD27 Ligand/TNFSF7/CD70 Recombinant Protein (C-Fc)
Human CD27 Ligand/TNFSF7/CD70 Recombinant Protein (C-Fc)
Price(USD):
Spec:
  • 50ug
  • 100ug
  • 1mg
Number:
Get quote
  • Overview

  • Images

  • References

  • Datasheet

  • SDS

Overview
Catalog No.HB796011
Description
Recombinant Human CD27 Protein, C-Fc (HB796011) expressed in Mammalian Cells, spanning Met1-Ile192.
Highlights
  • Fc Fusion — Enhanced stability with Protein A/G purification compatibility.
  • Mammalian Expression — Proper folding and native glycosylation.
  • High Purity — >90% purity verified by SDS-PAGE.
Expression systemMammalian cells
AccessionP26842
Protein lengthMet1-Ile192
ApplicationsELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
SpeciesHomo sapiens (Human)
Nature Recombinant
Tested applications WB
Endotoxin level Please contact with the lab for this information.
Purity >95% as determined by SDS-PAGE.
Predicted molecular weight 47.84 kDa
Form Lyophilized
Storage buffer Lyophilized from a solution in PBS pH 7.4, 1 mM EDTA, 4% Trehalose, 1% Mannitol.

Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.

Reconstitution Reconstitute in sterile water for a stock solution. Adjust the volume of sterile water so that, after reconstitution, the final stock concentration matches the value indicated on the product label or datasheet.

RECONSTITUTION PROTOCOL
1. Allow the product to be reconstituted and the reconstitution diluent to reach room temperature.
2. Tap or briefly centrifuge the product vial before opening to dislodge any lyophilized material that may be dispersed on the wall or cap of the vial.
3. Use the diluent and stock concentration recommended in the product datasheet. If preparing a stock concentration higher than recommended, contact Technical Service.
4. After adding the diluent, re-cap the vial and invert gently by hand or place on a slow rocking platform to allow the reconstitution diluent to coat all the surfaces inside the vial. Note: Do not mix by vortexing or by pipetting the material up and down.
5. Allow the vial to sit at room temperature with gentle agitation for at least 15 minutes before aliquotting or using.
6. Store the reconstituted material in single use aliquots in polypropylene or siliconized tubes. Aliquots of 10 μL or larger are recommended.
Shipping In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternate NamesCD27L receptor, TNFRSF7, T14, CD27 antigen, Tumor necrosis factor receptor superfamily member 7, CD27, T-cell activation antigen CD27
Background

CD27 antigen is a ~29 kDa protein. Costimulatory immune-checkpoint receptor expressed at the surface of T-cells, NK-cells and B-cells which binds to and is activated by its ligand CD70/CD27L expressed by B-cells. The CD70-CD27 signaling pathway mediates antigen-specific T-cell activation and expansion which in turn provides immune surveillance of B-cells. Mechanistically, CD70 ligation activates the TRAF2-PTPN6 axis that subsequently inhibits LCK phosphorylation to promote phenotypic and transcriptional adaptations of T-cell memory. In addition, activation by CD70 on early progenitor cells provides a negative feedback signal to leukocyte differentiation during immune activation and thus modulates hematopoiesis. Negatively regulates the function of Th2 lymphocytes in the adipose tissue.

1. Izawa, K. et al. (2017) The Journal of experimental medicine 214, 73-89. PMID: 28011863
2. Jaeger-Ruckstuhl, CA. et al. (2024) Immunity 57, 287-302.e12. PMID: 38354704
Note For research use only.
Images
  • Human CD27 Ligand/TNFSF7/CD70 Recombinant Protein (C-Fc)

    SDS-PAGE

    SDS-PAGE for Recombinant Human CD27 Protein, C-Fc

  • Human CD27 Ligand/TNFSF7/CD70 Recombinant Protein (C-Fc)

    Bioactivity

    Detects Varlilumab in indirect ELISAs.

  • Human CD27 Ligand/TNFSF7/CD70 Recombinant Protein (C-Fc)

    Bioactivity

    Detects Human CD27 Antibody (5F24) in indirect ELISAs.

  • Human CD27 Ligand/TNFSF7/CD70 Recombinant Protein (C-Fc)

    Western blot

    Detected by Anti-CD27 monoclonal antibody (Catalog No: HP628207)

References
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recommendation

Contact us for custom quotes, bulk requests and any other issues.

Mail: support@abinScience.com

Distributor list